Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Pre-Cessation Bupropion for Smoking Cessation
NCT00534001Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jan 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by Roswell Park Comprehensive Cancer Center. Started Jan 2006; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00534001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534001.